abstract OBJECTIVE: Overweight and obesity are increasingly prevalent in the general pediatric population. Evidence suggests that children with autism spectrum disorders (ASDs) may be at elevated risk for unhealthy weight. We identify the prevalence of overweight and obesity in a multisite clinical sample of children with ASDs and explore concurrent associations with variables identified as risk factors for unhealthy weight in the general population.
WHAT'S KNOWN ON THIS SUBJECT: Children and adolescents with autism spectrum disorders (ASDs) may be at elevated risk for unhealthy weight. Samples of children with verified clinical diagnoses of ASD have been lacking, and associations with child behavior and functioning are not well understood.
WHAT THIS STUDY ADDS:
Young children (2-5 years old) and adolescents (12-17 years old) with ASDs were at an elevated risk for unhealthy weight status compared with a general population sample. The presence of sleep or affective problems may confer increased risk among those with ASD.
Pediatric overweight and obesity are significant public health concerns. In 2011 and 2012, 31.8% of US children aged 2 to 19 years were overweight (BMI $85th percentile) 1 ; 16.9% were obese (BMI $95th percentile). 2 Unhealthy weight poses health risks including sleep-disordered breathing, 3 orthopedic problems, 4 type 2 diabetes, 5 hypertension and dyslipidemia, 6, 7 and reduced life spans regardless of adult weight status. 8 Unhealthy weight is also associated with family economic burden 9, 10 and harms psychosocial functioning 11, 12 : Children who are overweight or obese are more likely to be bullied 13 and socially isolated. 14 Thus, unhealthy weight in childhood has significant implications for current quality of life and future independent functioning. 15 Little is known about overweight and obesity in children with autism spectrum disorders (ASDs). 12 However, this issue is of increased public health importance because ASDs now affect 1 in 68 US children. 16 Although many risk factors for unhealthy weight are probably the same in children with ASDs as in the general pediatric population, 17, 18 children with ASDs may be vulnerable to additional risks. For example, problem eating behaviors such as food selectivity are common among children with ASDs, [19] [20] [21] which tends to coincide with preferences for a narrow range of low-nutrition, energy-dense foods and rejection of fruits, vegetables, and whole grains. 19, [22] [23] [24] Children with ASDs also spend more time in sedentary activities 25, 26 and have less regular physical activity. 27, 28 In addition, children with ASDs often take psychotropic medications, 29 many of which can cause weight gain. [30] [31] [32] Some children with ASDs may also have genetic vulnerabilities to obesity, such as 11p14.1 or 16p11.2 microdeletions. [33] [34] [35] Finally, having an ASD also increases the risk of comorbid problems 36, 37 associated with unhealthy weight in childhood, such as sleep difficulties, 3, 38 gastrointestinal (GI) disturbances, 39, 40 attention-deficit/hyperactivity disorder (ADHD), 41 and disorders such as anxiety 42 and depression. 43 The presence of these unique risk factors suggests that children with ASDs are at an elevated risk for being overweight or obese. However, prevalence estimates of unhealthy weight in ASD populations vary widely (Table 1) . In 4 previous studies with non-ASD comparison groups, prevalence of obesity was higher among those with ASDs, 24, [44] [45] [46] although the difference reached statistical significance in only 2 studies. 44, 45 A recent study 45 found significantly higher prevalence of both overweight and obesity among children with ASDs, with group risks associated with older age, public insurance, and co-occurring sleep disorders. 45 However, previous studies have been limited by small samples, 24 use of parent-reported anthropometrics, 44, 46 parentreported ASD diagnosis, 44, 46 or unconfirmed diagnoses present in medical records. 45, 47 Additionally, associations between unhealthy weight and child behavior and functioning are not well understood among children with ASDs.
The first aim of this study was to examine prevalence of unhealthy weight in a large multisite sample of children with confirmed ASDs, based on measured weight and height. We compared these prevalence estimates with those derived from a US general population sample from the NHANES. The second aim was to examine family-and child-level factors associated with unhealthy weight among children with ASDs. Our final aim was to examine hypotheses regarding associations between unhealthy weight and factors unique to children with ASDs. We hypothesized that unhealthy weight among children with ASDs would be associated with greater impairments in behavioral functioning (ASD symptoms, adaptive skills). Based on results from a smaller sample of children with ASDs in Oregon, 48 we also expected obese children with ASDs to experience more comorbid problems (sleep difficulties, ADHD, internalizing symptoms such as depression and anxiety) and be prescribed psychotropic medications more often than nonobese children with ASDs. 
METHODS

Participants
NHANES Comparison Sample
The NHANES is a representative cross-sectional sample of the US noninstitutionalized population and is described elsewhere. 2 Weight and height values in NHANES are collected via standardized physical examination. We used data from 3 consecutive NHANES surveys (6 years) to account for secular changes in prevalence of overweight or obesity. We restricted the sample to children aged 2 to 17 years to match the age range in the ATN (unweighted n = 8844; weighted estimate of the total population size 63 157 608). The Supplemental Appendix details prevalence estimations in NHANES.
ATN Measures Sociodemographics
Parents reported child gender, age, race or ethnicity, and parents' education. Race was reported in 6 categories; these were collapsed to white, black, and other races for analyses because of sample size constraints. Ethnicity was categorized as Hispanic or Latino origin or not Hispanic or Latino. Parent education was grouped as high school graduate or less, some college, or college graduate or higher.
BMI
Trained clinical staff measured children's weight and height using a metric scale and wall-mounted stadiometer. These values were converted to gender-specific BMI-forage percentiles based on Centers for Disease Control and Prevention (CDC) growth charts, 1 and CDC criteria were used to define overweight (BMI $85th percentile for age and gender) and obesity (BMI $95th percentile for age and gender). Underweight children (BMI ,5th percentile; n = 237) were included in the denominator for prevalence estimates in both the ATN and NHANES samples but excluded from within-ATN subgroup comparisons. 
Treatments
Behavioral Functioning
Trained clinicians scored ASD symptoms during the ADOS, 50 a standardized observational assessment; ADOS calibrated severity scores (total CSS) provided a measure of overall ASD symptom severity. 51, 52 Parents completed the Vineland Adaptive Behavior Scales (VABS-II), 53 which assesses functional skills and provides an Adaptive Behavior Composite as an estimate of overall adaptive functioning (mean = 100, SD = 15). We assessed intellectual functioning by using 1 of the following assessments (N = 3787): the full Stanford-Binet Scales of Intelligence (n = 753), 54 the abbreviated Stanford-Binet Scales of Intelligence (n = 1632), the Wechsler Intelligence Scale for Children, Fourth Edition (n = 141), 55 the Differential Ability Scales (n = 72), 56 the Wechsler Preschool and Primary Scale of Intelligence (n = 84), 57 the Wechsler Abbreviated Scale of Intelligence (n = 59), 58 the Leiter International Performance Scale-Revised (n = 108), 59 and the Mullen Scales of Early Learning (n = 938; Early Learning Composite Standard Scores). 60 Because Mullen Scales of Early Learning Early Learning Composite scores were skewed and could not be transformed, all children were grouped as IQ ,70 (intellectual disability range) or not.
Comorbid Problems
Parents reported on children's sleep difficulties via the Children's Sleep Habits Questionnaire (CSHQ), 61 62 The CBCL Anxiety Problems scale includes items identified by experts as related to generalized anxiety disorder and specific phobias. The Affective Problems scale includes anxiety/ depression, somatic complaints, and withdrawal. 63, 64 The CBCL Attention Problems scale includes items related to inattention and hyperactivity associated with ADHD.
Statistical Analyses
Overweight and Obesity Among Children With ASDs Compared With the General Population
The goal of these analyses was to determine whether prevalence of overweight ($85th percentile) or obesity ($95th) was greater in children with ASDs than in a general population sample (NHANES). Underweight children were included in both samples. Because of NHANES's complex sampling structure, we conducted all analyses after applying sampling weights, using the R Survey package. 65, 66 Weighted NHANES prevalence estimates were compared with those in the ATN sample via z tests. Within each set of comparisons (overweight and obesity), we adjusted P values to control Type I error rate at q , 0.05 by using the adaptive false discovery rate procedure (FDR). 67 Associations Healthy weight children were less frequently prescribed selective serotonin reuptake inhibitors (4.8%) than overweight (7.0%; V = 0.04, P = .02) or obese children (7.9%; V = 0.06, P , .001). Compared with obese children, healthy weight children were less frequently prescribed atypical neuroleptics (4.8% vs 8.1%; V = 0.06, P , .001) and asthma and allergy medications (7.1% vs 10.1%; V = 0.05, P = .02). However, total psychotropic medications prescribed (range 0-5) was significantly associated with BMI category (Kruskal-Wallis rank sum test x 2 = 10.2, P = .006). Pairwise Mann-Whitney U tests revealed that children in the obesity group received more medications than those in the healthy weight group (Cohen's d = 0.14; FDR adjusted P = .005).
DISCUSSION
In this multi-institutional sample of children with ASDs, 33.6% of children met criteria for overweight ($85th BMI percentile), and 18% met criteria for obesity ($95th BMI percentile). The prevalence estimate for overweight is comparable to the 31.8% prevalence among same-age children in the general population from NHANES. Prevalence of overweight and obesity among children with ASDs was significantly higher at younger age (2-5 years) and in adolescence (12-17 years) compared with the general population sample from NHANES. These prevalence estimates are consistent with recently reported estimates based on measured height and weight in people with ASDs. 45, 70 For example, Broder-Fingert et al 45 found significantly elevated rates of overweight (exclusive of obesity) and obese weight status among children with Asperger syndrome and autism compared with control children in every age category (2-5, 6-11, 12-15, and 16-20 years). In our analyses, prevalence of overweight and obesity was consistently higher for ASDs, except among children with ASDs ages 6-11 years. One explanation for this discrepancy may be that BroderFingert's control group had lower prevalence of overweight (inclusive of obesity) than this study's general population sample. For example, among children age 6-11 years, ,20% of children in Broder-Fingert's sample had BMI $85th percentile for gender and age, compared with 34.2% in NHANES.
Examination of cross-sectional prevalence estimates (Table 3 ) also suggests the possibility of different age-related trends among children with ASDs. For example, in the general population, prevalence of overweight was 10.9% higher among children ages 6 to 11 years than among those ages 2-5 years. In contrast, in the ATN, prevalence was only 1.9% higher among children age 6-11 versus 2-5 years. Because obesity becomes more prevalent among older children in the general population, 2 these findings may suggest a different trajectory of weight gain among children with ASD. The lack of differences in the prevalence of overweight and obesity between the ages of 6 and 11 years might reflect a stabilizing period, in which children with ASDs who gained weight earlier remain in the same BMI category. In contrast, children in the general population may be more likely to gain excess weight at older ages. Future longitudinal analyses could explore these trends in greater detail.
One surprising finding was the lack of differences between the ASD sample and the general population among children of non-Hispanic black origin. Environmental factors associated with obesity, such as socioeconomic status, are probably already elevated among black children 71, 72 and may overshadow additional risks associated with ASDs. Alternatively, given that the ATN constitutes a referred sample, black children in the ATN may be of higher socioeconomic status and therefore differ less systematically than white children, regardless of ASD status. However, this latter explanation would be inconsistent with the robust differences we found between Hispanic children in the ASD and general populations, because Hispanic children may also have elevated environmental risks. 73 Because the sample sizes of nonHispanic black children with ASDs in the ATN were small, group estimates may also be less reliable.
Among children with ASDs, there were several notable associations between sociodemographic variables and unhealthy weight. Multivariate analyses revealed that older age, Hispanic or Latino ethnicity, lower parent education, and sleep and affective problems were significantly associated with obesity. Many of these factors confirm previous findings in a smaller sample of children with ASDs in Oregon 48 and another recent large-scale study. 45 Because our study is cross-sectional, it is not clear whether comorbid sleep and affective problems are a cause or a consequence of obesity. Repeated measures could clarify these associations and might reveal important inroads to prevention and treatment of overweight and obesity among children with ASD.
Notably, some variables had no association with unhealthy weight among children with ASDs. In contrast to previous studies, 70, 74 there was no significant association between severity of ASD symptoms, and neither adaptive nor intellectual functioning was associated with overweight or obesity in multivariate models. In contrast to studies of typically developing children 75, 76 but consistent with previous research in children with ASDs, 77 GI problems were not linked to overweight or obesity. Also in contrast to findings in the general population, 41, 42 ADHD and anxiety problems were not associated with overweight or obesity. Thus, interventions that take into account both general risk factors for unhealthy weight and those that are ASD specific may hold promise for improved weight status in ASDs.
This study has limitations. Because it is a secondary data analysis, there was limited detail about sociodemographics, developmental and family history, GI problems, and medication dosages or duration of use. Our analysis of medications was limited by the available data in the ATN; other medications may have an impact on obesity that we were unable to estimate. For example, as 1 reviewer noted, medications with soporific effects could be linked to unhealthy weight status, but we were unable to explore these types of associations with the data collected. POTENTIAL CONFLICT OF INTEREST: Drs Zuckerman and Fombonne have received grants from Autism Speaks for other projects. Dr Fombonne has served as an expert witness on autism-related cases for AbbVie and GlaxoSmithKline. Dr Hill has indicated she has no potential conflicts of interest to disclose.
